These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24885450)

  • 1. Diverse attention deficits in patients with neurologically symptomatic and asymptomatic Wilson's disease.
    Iwański S; Seniów J; Leśniak M; Litwin T; Członkowska A
    Neuropsychology; 2015 Jan; 29(1):25-30. PubMed ID: 24885450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning in neurologically symptomatic and asymptomatic forms of Wilson's disease.
    Seniów J; Bak T; Gajda J; Poniatowska R; Czlonkowska A
    Mov Disord; 2002 Sep; 17(5):1077-83. PubMed ID: 12360563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive profile in Wilson's disease: a case series of 31 patients.
    Wenisch E; De Tassigny A; Trocello JM; Beretti J; Girardot-Tinant N; Woimant F
    Rev Neurol (Paris); 2013 Dec; 169(12):944-9. PubMed ID: 24120329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological impairment in Wilson's disease.
    Medalia A; Isaacs-Glaberman K; Scheinberg IH
    Arch Neurol; 1988 May; 45(5):502-4. PubMed ID: 3358700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social cognition in Wilson's disease: A new phenotype?
    Peyroux E; Santaella N; Broussolle E; Rigard C; Favre E; Brunet AS; Bost M; Lachaux A; Demily C
    PLoS One; 2017; 12(4):e0173467. PubMed ID: 28384152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease.
    Shribman S; Burrows M; Convery R; Bocchetta M; Sudre CH; Acosta-Cabronero J; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT
    Mov Disord; 2022 Aug; 37(8):1728-1738. PubMed ID: 35723521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective impairment of attentional networks of alerting in Wilson's disease.
    Han Y; Zhang F; Tian Y; Hu P; Li B; Wang K
    PLoS One; 2014; 9(6):e100454. PubMed ID: 24949936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of clinical rating scales in Wilson's disease.
    Volpert HM; Pfeiffenberger J; Gröner JB; Stremmel W; Gotthardt DN; Schäfer M; Weiss KH; Weiler M
    BMC Neurol; 2017 Jul; 17(1):140. PubMed ID: 28732478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and magnetic resonance imaging correlations in Wilson's disease.
    Frota NA; Barbosa ER; Porto CS; Lucato LT; Ono CR; Buchpiguel CA; Caramelli P
    Acta Neurol Scand; 2013 Jun; 127(6):391-8. PubMed ID: 23215772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplantation in Wilson's Disease with Neurological Impairment: Evaluation in 4 Patients.
    Laurencin C; Brunet AS; Dumortier J; Lion-Francois L; Thobois S; Mabrut JY; Dubois R; Woimant F; Poujois A; Guillaud O; Lachaux A; Broussolle E
    Eur Neurol; 2017; 77(1-2):5-15. PubMed ID: 27866189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mild cognitive impairment and depressive symptoms in patients with Wilson's disease under long-term therapy].
    Günther P; Hermann W
    Fortschr Neurol Psychiatr; 2012 Mar; 80(3):149-53. PubMed ID: 22407412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of neurological Wilson's disease with corpus callosum abnormalities.
    Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM
    BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson's Disease.
    Arguedas D; Stewart J; Hodgkinson S; Batchelor J
    Neurocase; 2015; 21(2):154-61. PubMed ID: 24499483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of copper toxicity on response inhibition processes: a study in Wilson's disease.
    Stock AK; Reuner U; Gohil K; Beste C
    Arch Toxicol; 2016 Jul; 90(7):1623-30. PubMed ID: 26438404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Global Assessment Scale for Wilson's Disease (GAS for WD).
    Aggarwal A; Aggarwal N; Nagral A; Jankharia G; Bhatt M
    Mov Disord; 2009 Mar; 24(4):509-18. PubMed ID: 19115420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unified Wilson's Disease Rating Scale - a proposal for the neurological scoring of Wilson's disease patients.
    Członkowska A; Tarnacka B; Möller JC; Leinweber B; Bandmann O; Woimant F; Oertel WH
    Neurol Neurochir Pol; 2007; 41(1):1-12. PubMed ID: 17330175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain susceptibility changes in neurologically asymptomatic pediatric patients with Wilson's disease: evaluation with quantitative susceptibility mapping.
    Saracoglu S; Gumus K; Doganay S; Koc G; Kacar Bayram A; Arslan D; Gumus H
    Acta Radiol; 2018 Nov; 59(11):1380-1385. PubMed ID: 29482344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric and behavioral abnormalities in Wilson's disease.
    Akil M; Brewer GJ
    Adv Neurol; 1995; 65():171-8. PubMed ID: 7872138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological aspects of Wilson's disease.
    Rathbun JK
    Int J Neurosci; 1996 Apr; 85(3-4):221-9. PubMed ID: 8734560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with treated and clinically stable Wilson's disease.
    Svetel M; Pekmezović T; Tomić A; Kresojević N; Potrebić A; Ješić R; Kostić VS
    Mov Disord; 2011 Jul; 26(8):1503-8. PubMed ID: 21594897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.